Some studies show that a nasal spray called esketamine helps with severe depression, but other bigger studies don’t show the same level of help—so scientists are confused about whether it really works as well as first thought.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses 'reported discrepancies,' which indicates an observation or pattern noted in data without asserting causation or certainty. 'Reported' implies findings from studies, and 'discrepancies' suggests a difference observed, not proven.
Context Details
Domain
medicine
Population
human
Subject
the efficacy of intranasal esketamine
Action
are reported discrepancies in
Target
between phase II and phase III clinical studies in patients with treatment-resistant or major depressive disorder
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
The study says that in early tests, the nasal spray worked well, but in later, bigger tests, the results weren’t as consistent — which is exactly what the claim is saying.